Mustang Bio
MBIO
75 hedge funds and large institutions have $48.4M invested in Mustang Bio in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 20 reducing their positions, and 10 closing their positions.
30% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 10
30% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 20
6% more capital invested
Capital invested by funds: $45.9M → $48.4M (+$2.53M)
3% more funds holding
Funds holding: 73 → 75 (+2)
0% more ownership
Funds ownership: 0.04% → 0.04% (+0%)
57% less call options, than puts
Call options by funds: $408K | Put options by funds: $952K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.16M |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$2.15M |
| 3 |
Two Sigma Advisers
New York
|
+$1.6M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.48M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$1.27M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.18M |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.17M |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$965K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$932K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAM
76
Panagora Asset Management
Boston,
Massachusetts
| $2K | +$2.46K | +1 | New |
|
|
TF
77
TimeScale Financial
Danvers,
Massachusetts
| $1K | – | – | – |
|
|
78
Alyeska Investment Group
Chicago,
Illinois
| – | -$1.18M | -496 | Closed |
|
|
CH
79
CVI Holdings
Wilmington,
Delaware
| – | -$1.17M | -491 | Closed |
|
|
PHP
80
Parkman Healthcare Partners
Stamford,
Connecticut
| – | -$965K | -405 | Closed |
|
|
SM
81
Sabby Management
Miami Beach,
Florida
| – | -$747K | -313 | Closed |
|
82
Arrowstreet Capital
Boston,
Massachusetts
| – | -$249K | -104 | Closed |
|
83
Acadian Asset Management
Boston,
Massachusetts
| – | -$137K | -57 | Closed |
|
|
MIH
84
Meitav Investment House
Bene-Beraq,
Israel
| – | -$95K | -40 | Closed |
|
|
CSS
85
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$83K | -35 | Closed |
|
86
SG Americas Securities
New York
| – | -$50K | -21 | Closed |
|
|
PHK
87
Point72 Hong Kong
Hong Kong
| – | -$18K | -7 | Closed |
|
MBIO Hedge Fund Activity: Q3 2020 in Review
75 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q3 2020, worth a combined $48.4M — up 5.5% from $45.9M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new MBIO positions and 10 closed out — a net gain of 3 holders — while 26 added to existing stakes and 20 trimmed.
The largest buyer was Millennium Management, adding an estimated $2.16M. The largest seller was Renaissance Technologies, cutting an estimated $1.27M.
- 75 institutional investors held Mustang Bio (MBIO) as of Q3 2020, up from 73 in Q2 2020.
- Funds reported $48.4M of Mustang Bio stock for Q3 2020, up 5.5% quarter-over-quarter.
- 13 funds opened new Mustang Bio positions in Q3 2020 and 10 closed out, a net change of +3 holders.
- The largest Mustang Bio buyer in Q3 2020 was Millennium Management, an estimated $2.16M added.
- The largest Mustang Bio seller in Q3 2020 was Renaissance Technologies, an estimated $1.27M sold.
Based on aggregated 13F filings for Q3 2020.